A retrospective cohort study evaluating a hospital post-discharge telephone consultation service found that clinical pharmacists were more than twice as likely to detect medication-related problems as physicians or registered nurses, despite clinicians across disciplines applying similar clinical interventions once problems were recognized. Researchers examined records from the Talk-To-You-Tomorrow telephone follow-up service operated by Eastern Health, a major tertiary public health network in Melbourne, Australia. The investigation analyzed 3,815 consultation records collected between June 2022 and May 2023 for adult patients recently discharged from the hospital’s general medicine unit. Among the consultations reviewed, clinicians flagged medication-related problems in 526 eligible patients, and each documented problem received at least one structured clinical intervention. Statistical analysis revealed that while the specific types of interventions chosen to resolve issues did not differ significantly between pharmacists and non-pharmacist practitioners, the rate of initial problem identification varied considerably across clinical backgrounds.
Patients discharged from general medicine wards frequently present with heightened clinical vulnerability and complex medical histories, placing them at increased risk for treatment misadventures during transitional care. During an acute hospital admission, older adults often experience significant changes to their pre-existing pharmacotherapy, including the addition of short-term therapies, dose titrations, or the discontinuation of chronic treatments. When communication lapses occur or discharge instructions are insufficiently understood, patients may encounter unintentional discrepancies, omissions when restarting baseline medications, or the inappropriate continuation of acute treatments. These transition-related breakdowns contribute directly to persistent symptoms, adverse drug events, and avoidable hospital readmissions. Structured post-discharge telephone follow-up initiatives have emerged across healthcare systems to bridge this vulnerable transition window, mitigating medication misadventures and reinforcing discharge instructions within the critical initial days following hospital departure.
The Talk-To-You-Tomorrow program evaluated in the study was staffed by an interdisciplinary clinical team comprising general medicine consultants, geriatricians, registered nurses with geriatric or general medicine expertise, and experienced clinical pharmacists. Operating within routine hospital practice, eligible general medicine patients were triaged at the point of discharge, with initial phone consultations conducted within 24 to 48 hours following departure. Each scheduled telephone encounter lasted between 20 and 30 minutes, during which clinicians reviewed patient well-being, verified discharge paperwork, performed medication reconciliation, confirmed patient comprehension, and arranged onward referrals when indicated. In clinical practice, triaging processes assigned patients based on clinical complexity, such that patients who underwent multiple in-hospital regimen alterations were systematically prioritized for pharmacist-led consultations, while medical clinicians and clinic staff coordinated overall allocations at the beginning of each shift.
To evaluate clinical interventions systematically, the research team classified recorded actions using the Swiss Society of Public Health Administration and Hospital Pharmacists tool, which adapts the four established domains of the Pharmaceutical Care Network Europe taxonomy: patient-level, drug-level, prescriber-level, and other interventions. Identified medication-related problems were transformed into standardized categories using the Drug Evaluation Tools framework, structured around necessity, effectiveness, safety, and adherence. The primary study outcome compared the distribution of intervention categories implemented by pharmacists against those employed by non-pharmacist clinicians, comprising doctors and nurses. Secondary endpoints assessed the specific classifications of medication problems detected, identified contributing patient factors and implicated therapeutic agents, and evaluated overall problem detection rates by clinician profession using binary logistic regression models.
Within the eligible cohort of 526 patients with confirmed medication problems, clinicians executed a total of 526 primary interventions, including 227 delivered by pharmacists and 299 delivered by non-pharmacist practitioners. Across the broad comparison between pharmacists and all non-pharmacist clinicians, the researchers identified no statistically significant difference in the distribution of intervention categories. Patient-level interventions represented the predominant approach utilized by all practitioners, accounting for the vast majority of documented resolutions across clinical disciplines. Prescriber-level actions were the least frequently utilized domain across both comparison groups, occurring in 5.3 percent of pharmacist encounters and 4.7 percent of non-pharmacist consultations, reflecting the direct-to-patient nature of telephone consultations.
Despite overall broad alignment between pharmacist and non-pharmacist cohorts, granular discipline-specific comparisons uncovered distinct operational variations among individual professions. Non-pharmacist clinicians as an aggregate group executed a higher proportion of drug-level interventions at 18.0 percent compared to 13.2 percent among pharmacists. Conversely, pharmacists engaged in liaison interventions with external healthcare providers in 7.9 percent of their encounters, compared to 4.7 percent among non-pharmacists. When analyzed by specific profession, statistically significant differences emerged when doctors were compared individually against pharmacists and against registered nurses, whereas direct comparisons between pharmacists and nurses revealed no statistically significant divergence in intervention distribution. These observed variances reflect underlying scope-of-practice differences, as medical officers served as the sole licensed prescribers embedded within the telephone consultation team.
Substantial differences were documented in the rates at which healthcare professions detected medication discrepancies during follow-up calls. Across the 3,815 consultation records evaluated, medical consultations constituted the largest volume, identifying medication problems in 10.9 percent of encounters, which was comparable to the 10.1 percent identification rate recorded by nursing personnel. Clinical pharmacists, however, identified medication-related problems in 22.7 percent of their consultations. After adjusting for potential confounding variables in binary logistic regression analysis, the odds of a pharmacist identifying a medication-related problem were 2.27 times greater than those of non-pharmacist clinicians. Despite these marked differences in detection frequency, the underlying nature of the medication problems identified did not differ significantly across clinician groups, with adherence concerns emerging as the most prevalent issue encountered by all providers.
Detailed review of the implicated pharmacotherapy identified 805 individual medications associated with the documented problems, with cardiovascular system agents representing the largest single category at 31.6 percent of implicated drugs. Medications targeting the alimentary tract and metabolism accounted for 18.5 percent, nervous system medications constituted 15.2 percent, and systemic anti-infective agents represented 9.4 percent. Utilizing the High-Alert Medications Stratified Revised scoring system, investigators determined that 13.8 percent of the implicated drugs qualified as high-alert medications, while the remaining therapies fell into the low-alert tier, with none exceeding the highest risk threshold. Baseline clinical profiling of the affected patient cohort demonstrated substantial comorbid burden, reflected by a median age-adjusted Charlson Comorbidity Index score of 5, alongside extensive therapeutic complexity indicated by a median of 11 discharge medications and 4 regimen modifications during inpatient admission.
The study authors highlighted several methodological limitations inherent to the retrospective, real-world observational design. Because patients were evaluated during a single consultation without independent cross-examination by multiple clinicians, unmeasured patient-level variations could not be fully controlled. The routine triaging protocol, which directed patients with multiple in-hospital medication adjustments toward pharmacist consultations, introduced potential selection bias that may have contributed to the elevated problem detection rate observed among pharmacists. Additionally, staffing variability across roster rotations, manual electronic documentation practices, and the absence of a single standardized diagnostic screening instrument represented potential sources of procedural heterogeneity. Regression modeling for patient-level predictive factors also yielded a low explanatory value, indicating that additional clinical variables are required to reliably forecast post-discharge medication problems.
In their concluding synthesis, the researchers emphasized that while clinicians from medicine, nursing, and pharmacy rely on comparable patient-centered interventions to address transitional treatment gaps, pharmacists demonstrate exceptional proficiency in uncovering medication-related problems following discharge. The findings highlight the specialized clinical value of integrating clinical pharmacists into multidisciplinary transitional care teams to safeguard medication continuity. In response to the study’s observations regarding the frequency of transitional medication complications, local hospital leadership reviewed and updated institutional discharge procedures to mitigate medication risks earlier in the care transition. The authors noted that future investigations should explore the cost-effectiveness of routine pharmacist-led transitional reviews and assess whether standardized detection frameworks can further optimize patient safety during post-hospital transitions.
Subject of Research: Comparison of clinical interventions and medication-related problem identification across healthcare professions in a post-discharge telephone follow-up service
Article Title: Evaluation of clinical interventions made by pharmacists, doctors and nurses in a hospital post-discharge telephone service: a retrospective cohort study
Article References: Leong, K. C., Meanger, D., Wu, P., Wong, A., Tee, W. T., Simango, M., & Levkovich, B. (2026). Evaluation of clinical interventions made by pharmacists, doctors and nurses in a hospital post-discharge telephone service: a retrospective cohort study. International Journal of Clinical Pharmacy, 48(6), 2289-2298. https://doi.org/10.1007/s11096-026-02207-y
Image Credits: AI Generated
DOI: 10.1007/s11096-026-02207-y
Keywords: post-discharge care, clinical pharmacy, medication-related problems, telephone follow-up, transitional care, Eastern Health, retrospective cohort study, patient safety, interdisciplinary healthcare, medication reconciliation, general medicine, high-alert medications, drug evaluation tools, PCNE classification, medication adherence, clinical interventions
News Source: Ophelia Keating. (November 19, 2026). Pharmacists Identified More Post-Discharge Medication Problems Than Physicians and Nurses. Scienmag.



